Skip to content
Primex Pharmaceuticals
  • Primex
    • Company
    • Business Model
    • People
    • Careers
    • Key Figures
  • News
  • Portfolio
    • Strategy
    • Recofol
    • Ogna
    • OZALIN / OZASED
    • Pipeline
  • Partners
  • Contact
Primex_ADV6209_girl_h

News

May 31, 2018

Primex participates in European Society of Anesthesiology Congress in Copenhagen 2-4th June

Primex Pharmaceuticals invites all the Euroanaesthesia 2018 delegates to join the ESA 2018 Industry Sponsored Symposium: Paediatric Sedation: Are There Areas for Improvement? on Sunday 3rd of June at 12:00.

Register to live stream Primex Pharmaceuticals industry sponsored symposium from here.

Symposiu_AD_Primex_ESA2018

Primex Pharmaceuticals with the support of TheSi Farma, launch OZASED® in Italy

Read More ...

OZALIN® continues to receive marketing authorization approvals across EU

Read More ...

Primex Pharmaceuticals and Nordic Group sign a strategic partnership to commercialise OZALIN® in France

Read More ...

Primex Pharmaceuticals and POA Pharma sign a strategic partnership to commercialise OZALIN in the Nordic region.

Read More ...

Primex Pharmaceuticals AG announces it has received marketing authorization (MA) in the EU for OZALIN®

Read More ...

Primex Pharmaceuticals Appoints Tomaso Dameno as Head of Operations

Read More ...

Primex Pharmaceuticals AG presents ADV6209* at Euroanaesthesia 2018

Read More ...
Top
Primex Pharmaceuticals

© 2018 Primex Pharmaceuticals. All Rights Reserved.

Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy